Patients with breast tumors that do not express the estrogen receptor, the progesterone
receptor, nor Her-2/neu are hence termed “triple negatives”, and generally have a poor …

Over the past decade, precision medicine (PM) approaches have received significant
investment to create new therapies, learn more about disease processes, and potentially …

Background: This study sought to determine the prevaccine type-specific prevalence of
human papillomavirus (HPV)–associated cancers in the United States to evaluate the …

Background Proactive recommendations for human papillomavirus (HPV) vaccines in Japan
have been suspended for 5 years because of safety concerns. While no scientific evidence …

Background Vaccination is the one of the agendas of many countries to reduce cervical
cancer caused by the Human papillomavirus. Currently, VLP-based vaccine is the most …

Human papillomavirus (HPV) infection plays a key role in the development of cervical
cancer. The aim of the current study was to investigate the HPV type distribution in Chinese …

Abstract Background The story of Human Papillomavirus vaccination demands reflection not
only for its public health impact on the prophylactic management of HPV disease, but also …

A next generation nonavalent human papillomavirus (HPV) vaccine (“HPV9 vaccine”) is
being introduced in several countries. The aims of this study were to evaluate whether …

Anal squamous cell carcinoma is a human papillomavirus-related disease, in which no
substantial advances in treatment have been made in over 40 years, especially for those …

Background Many studies investigate HPV vaccine acceptability, applying health behavior
theories to identify determinants; few include real uptake, the final variable of interest. This …